Skip to main content

Angiopoietin-like Protein 4/ANGPTL4: Proteins and Enzymes

Angiopoietin-like 4 (ANGPTL4), also known as FIAF, FARP, and PGAR, is a 55 kDa glycoprotein secreted by the liver and fat tissue. It contains an N-terminal coiled coil domain and a C-terminal fibrinogen-like domain which can be proteolytically separated. The coiled coil domain mediates the formation of variable-sized disulfide-linked oligomers. This domain directly inhibits lipoprotein lipase (LPL), resulting in increased circulating triglyceride levels.

ANGPTL4 circulates in association with HDL lipoproteins. Its expression in adipose tissue is induced by fasting and suppressed by feeding. In hypoxic areas, ANGPTL4 is induced in both vascular endothelial cells and tumor cells. The N-terminal fragment can function as an angiogenesis inhibitor. In contrast, the C-terminal fragment modulates cell adhesion through interactions with heparan sulfate proteoglycans, Integrins alpha 1 and beta 5, Vitronectin, and Fibronectin, thereby promoting keratinocyte migration and wound healing. ANGPTL4 additionally enhances the survival of hematopoietic and mesenchymal stem cells.

Products:

Show More

7 results for "Angiopoietin-like Protein 4/ANGPTL4 Proteins and Enzymes" in Products

7 results for "Angiopoietin-like Protein 4/ANGPTL4 Proteins and Enzymes" in Products

Angiopoietin-like Protein 4/ANGPTL4: Proteins and Enzymes

Angiopoietin-like 4 (ANGPTL4), also known as FIAF, FARP, and PGAR, is a 55 kDa glycoprotein secreted by the liver and fat tissue. It contains an N-terminal coiled coil domain and a C-terminal fibrinogen-like domain which can be proteolytically separated. The coiled coil domain mediates the formation of variable-sized disulfide-linked oligomers. This domain directly inhibits lipoprotein lipase (LPL), resulting in increased circulating triglyceride levels.

ANGPTL4 circulates in association with HDL lipoproteins. Its expression in adipose tissue is induced by fasting and suppressed by feeding. In hypoxic areas, ANGPTL4 is induced in both vascular endothelial cells and tumor cells. The N-terminal fragment can function as an angiogenesis inhibitor. In contrast, the C-terminal fragment modulates cell adhesion through interactions with heparan sulfate proteoglycans, Integrins alpha 1 and beta 5, Vitronectin, and Fibronectin, thereby promoting keratinocyte migration and wound healing. ANGPTL4 additionally enhances the survival of hematopoietic and mesenchymal stem cells.

Products:

Show More

C-Terminal Fragment

Source: NS0
Accession #: Q9Z1P8
Applications: BA
Recombinant Mouse Angiopoietin-like Protein 4/ANGPTL4 Binding Activity
Source: NS0
Accession #: Q9BY76
Applications: InhibAct
R&D Systems Recombinant Proteins and Enzymes
Source: CHO
Accession #: Q9Z1P8
Applications: InhibAct
R&D Systems Recombinant Proteins and Enzymes

N-Terminal Fragment

Source: CHO
Accession #: Q9BY76
Applications: BA
Recombinant Human Angiopoietin-like 4 Biotin Protein Bioactivity
Source: NS0
Accession #: Q9BY76
Applications: BA
Recombinant Human Angiopoietin-like 4 Biotin Protein Bioactivity
Source: CHO
Accession #: Q9BY76
Applications: BA
R&D Systems Recombinant Proteins and Enzymes
Source: NS0
Accession #: Q9BY76
Applications: InhibAct
R&D Systems Recombinant Proteins and Enzymes
Results Per Page
5 10 25 50
/ 1